# US 2025/0082704 A1 · Maqui berry extracts for use in the treatment or prevention of bone disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082704 A1
- Document ID: US20250082704A1
- Status: Published application
- Kind: A1
- Application number: 18/958,054
- Filed: 2024-11-25
- Published: 2025-03-13
- Earliest claimed: 2019-02-27
- Assignees: Anklam Extrakt GmbH
- Applicants: Anklam Extrakt GmbH
- Inventors: Bernd BONNLÄNDER; Stefanie LANG; Keiko SUZUKI
- Web page: https://patentgrep.com/patent/US20250082704A1

## CPC

- A61K 36/185: Magnoliopsida (dicotyledons)
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61P 19/00: Drugs for skeletal disorders
- A61K 2236/00: Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K 2236/53: Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates generally to maqui berry for use in the treatment or prevention of bone injuries, diseases or defects, the promotion of healing of bone injuries, and the promotion of bone formation. Particular embodiments as disclosed herein find application in, inter alia, the treatment of bone fractures and in bone formation and regeneration. In particular, the present invention relates to the use of maqui berry extract in the manufacture of a medicament or dietary supplement for use in treating or preventing of bone injury or diseases or defects selected from the group of congenital bone defects, bone or spinal deformation, osteosarcoma, bone dysplasia, osteomalacia (rickets), osteogenesis imperfecta (brittle bone disorder), Paget's disease of the bone, osteoarthritis.

## Claims

### Claim at position 1

-10. (canceled)

### Claim 11

A method of treatment or prevention of a bone disease or defect selected from the group of congenital bone defects, bone or spinal deformation, osteosarcoma, bone dysplasia, osteomalacia (rickets), osteogenesis imperfecta (brittle bone disorder), Paget's disease, comprising administering to a subject in need of said treatment or prevention an effective amount of a maqui berry extract, wherein the maqui berry extract comprises a minimum of 25% (w/w) delphinidins and a minimum of 35% (w/w) anthocyanins, and wherein the extract is obtained by the following steps:
a) providing a crude extract of a plant material,
b) filtering said crude extract;
c) contacting said crude extract with an adsorbent, wherein said adsorbent, wherein the adsorbent is a resin which adsorbs said anthocyanins;
d) washing said adsorbent; and
e) eluting said anthocyanins from said adsorbent to obtain a composition enriched for anthocyanins.

### Claim 12 (depends on 11)

The method according to claim 11, wherein the maqui berry extract is obtained by an aqueous/alcoholic extraction agent.

### Claim 13 (depends on 11)

The method according to claim 11, wherein the maqui berry extract is obtained by an aqueous/alcoholic extraction agent, in a ratio of 40:60 (v/v) to 60:40 (v/v).

### Claim 14 (depends on 11)

The method according to claim 11, wherein the maqui berry extract is obtained by an aqueous/alcoholic extraction agent, in a ratio of 41:59 (v/v).

### Claim 15 (depends on 11)

The method according to claim 11, wherein the maqui berry extract is obtained by an aqueous/alcoholic extraction agent, in a ratio of 50:50 (v/v).

### Claim 16 (depends on 12)

The method according to claim 12, wherein the alcoholic extraction agent is ethanol.

### Claim 17 (depends on 12)

The method according to claim 12, wherein the alcoholic extraction agent is ethanol, in 96% ethanol.

### Claim 18 (depends on 11)

The method according to claim 11, wherein water is used for step d.) and ethanol is used for step e.).

### Claim 19 (depends on 11)

The method according to claim 11, wherein the plant material of step a.) is selected from fruits.

### Claim 20 (depends on 11)

The method according to claim 11, wherein said adsorbent of steps c.) to d.) is a resin.

### Claim 21 (depends on 20)

The method according to claim 20, wherein said resin is a polymer resin or a polystyrene resin.

### Claim 22 (depends on 11)

The method according to claim 11 wherein the maqui berry extract is in a pharmaceutical preparation comprising a carrier substance, wherein the pharmaceutical preparation is in the form of dragées, tablets, film-coated tablets, powders, capsules or liquid dilutions, solid preparations for inhalation, compresses, wound and gum dressings, tamponades, tonsil paint solutions, gargling solutions, rinsing solutions, injections, transfusion solutions, granules, enteric coated tablets, troches, suspensions, fomentations, nasal drops, inhalants, lotions, suppositories, or enteral nutrients.

### Claim 23 (depends on 11)

The method according to claim 11 wherein the maqui berry extract is in a pharmaceutical preparation comprising a carrier substance, wherein the carrier substance is in the form of dragées, tablets, film-coated tablets, powders, capsules, drops, juices or syrups, ointments, emulsions, granulates, powders, nasal sprays, liquid or solid preparations for inhalation, compresses, wound and gum dressings, tamponades, tonsil paint solutions, gargling solutions, rinsing solutions, injections, transfusion solutions, granules, enteric coated tablets, troches, suspensions, fomentations, nasal drops, inhalants, lotions, suppositories or enteral nutrients.
